Skip to main content
. 2016 Jul 6;9:72–76. doi: 10.1016/j.amsu.2016.07.004

Table 1.

Patient demographics, tumor characteristics and operative characteristics.

No-MBP group (n = 97) MBP group (n = 159) p
Patient demographics
Sex 0.70
 Male 55 (56.7%) 85 (53.5%)
 Female 42 (43.3%) 74 (46.5%)
Mean age (years) 70.73 ± 10.09 70.71 ± 11.68 0.99
ASAa
 1 17 (17.5%) 16 (10.1%)
 2 59 (60.8%) 101 (63.9%)
 3 21 (21.6%) 41 (25.9%) 0.21
Neoadjuvant chemoirradiation 0% 0%
Tumour characteristics
Location 0.17
 Caecum & ascending colon 15 (15.4%) 36 (22.6%)
 Hepatic flexure 16 (16.5%) 11 (6.9%)
 Transverse colon 10 (10.3%) 13 (8.2%)
 Splenic flexure 6 (6.2%) 5 (3.1%)
 Descending colon 8 (8.2%) 21 (13.2%)
 Sigmoid colon 28 (28.9%) 48 (30.2%)
 Upper rectum & rectosigmoid junction 14 (14.4%) 25 (15.7%)
 Mean tumor size (cm) 4.3 ± 2.1 4.5 ± 1.8 0.35
Cancer stageb
 Early (Stage 0–II) 55 (56.7%) 88 (55.0%)
 Advanced (Stage III–IV) 42 (43.3%) 72 (45.0%) 0.79
Operation characteristics
Duration (min) 155.8 ± 44.4 165.0 ± 45.0 0.11
Blood loss, estimated (ml) 108.2 ± 123.0 107.3 ± 115.0 0.96
Type 0.70
 Right hemicolectomy 37 (38.1%) 53 (33.3%)
 Extended right hemicolectomy 4 (4.1%) 6 (3.8%)
 Left hemicolectomy 11 (11.3%) 28 (17.6%)
 Sigmoid colectomy 4 (4.1%) 5 (3.1%)
 Anterior resection 41 (42.3%) 67 (42.1%)
Diversion Stoma 0% 0%
Conversion 5 (5.2%) 11 (6.9%) 0.57
a

American Society of Anesthesiologists.

b

Cancer of Colon Staging using American Joint Committee on Cancer 7th revision.